Date Filing Filing Description Download
Apr 06, 2018 8-K Current report filing
Apr 06, 2018 424B3 Prospectus filed pursuant to Rule 424(b)(3)
Apr 06, 2018 S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
Mar 29, 2018 8-K Current report filing
Mar 29, 2018 4 Statement of Changes in Beneficial Ownership
Mar 29, 2018 4 Statement of Changes in Beneficial Ownership
Mar 29, 2018 4 Statement of Changes in Beneficial Ownership
Mar 12, 2018 4 Statement of Changes in Beneficial Ownership
Mar 07, 2018 8-K/A Amended Current report filing
Mar 01, 2018 10-K Annual Report
Feb 28, 2018 4 Statement of Changes in Beneficial Ownership
Feb 26, 2018 8-K Current report filing
Feb 13, 2018 SC 13G Statement of Ownership
Feb 13, 2018 SC 13G/A Amended Statement of Ownership
Feb 12, 2018 SC 13G/A Amended Statement of Ownership
Feb 09, 2018 SC 13G/A Amended Statement of Ownership
Feb 07, 2018 SC 13G Statement of Ownership
Jan 23, 2018 SC 13G/A Amended Statement of Ownership
Jan 08, 2018 4 Statement of Changes in Beneficial Ownership
Jan 05, 2018 8-K Current report filing

NYSE: DPLO

-0.20 -0.95% $ 20.85 Volume: 243,772 Common Stock | 20 minute delay April 20, 2018

Investor Contact

Atul Kavthekar, CFO

Investor Relations,
Diplomat Pharmacy Inc.
akavthekar@diplomat.is

Phone: 810.768.9380

Email Now